DPYD Testing
The DPYD Screen test is a genetic test intended to reduce severe toxic and adverse events and improve treatment outcomes for cancer patients receiving fluoropyrimidine drugs.
- The description claims that the test may be particularly important for cancer patients undergoing therapy with fluoropyrimidine drugs like Fluorouracil (5-FU) and Capecitabine.
How AI sees this product
The more complete this product's details, the more confidently AI assistants can understand and recommend it.
61%